Summary of New Wei Medical Conference Call Company Overview - New Wei Medical focuses on interventional brain-machine interface technology, utilizing a minimally invasive approach through the jugular vein to access brain vessels for signal collection, differentiating itself from invasive technologies like those developed by Musk's company [2][5] Key Points and Arguments - **Product Development Timeline**: New Wei Medical plans to complete type testing and animal experiments by mid-2026, initiate clinical enrollment in the second half of 2026, and expects to finish all patient enrollment and submit for regulatory approval by 2028 [2][3][4] - **Independent Subsidiary**: The company has established an independent subsidiary named "Wei Brain Technology" to focus on the development of interventional brain-machine interfaces and related investment collaborations, with plans to expand the team to 20 members [2][9] - **Technical Specifications**: The interventional brain-machine interface device uses a nickel-titanium alloy stent with electrode configurations of 4 or 16 channels, with signal processing chips placed subcutaneously beneath the clavicle [2][8] - **Animal Testing Results**: Animal experiments have shown stable signal strength, with a small-tailed sheep experiment maintaining 97%-98% signal strength after 18 months, validating the feasibility of the technology [2][11] Competitive Landscape - **Comparison with Musk's Technology**: New Wei Medical's approach avoids the need for craniotomy, which is required by Musk's invasive technology. This results in lower surgical risks and higher patient acceptance. The company claims its method ensures stable signal transmission due to the encapsulation of the electrode stent by the vessel wall, preventing displacement issues [5][10] Clinical Trial Plans - **First Patient Enrollment**: The company plans to conduct its first clinical trial in 2026, targeting 30-50 patients primarily for limb rehabilitation indications, with a follow-up period of approximately six months [4][10] - **Regulatory Recognition**: New Wei Medical is the only approved project for interventional technology routes in a national initiative co-hosted by the Ministry of Industry and Information Technology and the National Medical Products Administration, indicating recognition of its innovative technology [4][6] Challenges and Future Directions - **Technical Limitations**: The interventional approach may face challenges in accessing smaller, more distal blood vessels, necessitating the design of smaller electrode stents for broader brain area applications [11][12] - **Future Applications**: The company aims to extend its technology from motor function areas to visual and auditory functions, as well as explore emotional management and other research directions [11][12] Additional Insights - **Market Potential**: With 2,500 hospitals in China capable of performing the minimally invasive procedure, New Wei Medical is positioned to leverage a broad market for its technology [5] - **Investment and Collaboration**: The subsidiary aims to attract external partnerships and capital to enhance its operational capabilities and cover more consumer-level application scenarios [9]

Group 1: Brain-Computer Interface (BCI) Development - The world's first invasive brain-computer interface successfully restored motor function in a paralyzed patient in China, led by a team from Nankai University and local hospitals [1] - The BCI technology is expected to experience explosive growth in the next 3 to 5 years, driven by policy support and technological breakthroughs, with both invasive and non-invasive product developments progressing [2] - Companies like Rongtai Health and Aoyi Technology are collaborating to advance brain-machine integration technology and its applications in smart health [2] Group 2: Cross-Border Payment Innovations - The launch of the Cross-Border Payment System marks a significant innovation, allowing real-time cross-border remittances between mainland China and Hong Kong [3] - This system is expected to enhance the efficiency of cross-border payments and expand the offshore business scale of the renminbi, providing new profit growth points for banks [3] - Companies like Xiaogongshangcheng and Lakala are actively investing in cross-border payment services, with Lakala reporting a 76% increase in cross-border merchant scale and an 85% increase in transaction volume year-on-year [3] Group 3: Carbon Fiber Material Expansion - Carbon fiber materials are increasingly being used in various industries, with a projected demand of 11,700 tons in the electric vertical takeoff and landing aircraft sector by 2030, creating a new market worth over 10 billion [4] - The price of T300-grade carbon fiber has dropped by 70% to around 60,000 yuan per ton, facilitating its use in more industries [4] - The carbon fiber market in China is expected to reach approximately 17.14 billion yuan in 2024, with an 8.16% year-on-year production growth and a 119.9% increase in exports [4] Group 4: Solid-State Battery Advancements - Solid-state batteries are entering a critical development phase, with expectations for widespread application in low-altitude economy, robotics, and new energy vehicles [6] - The global shipment of solid-state batteries is projected to reach 614.1 GWh by 2030, with a market size exceeding 250 billion yuan [6] - Companies like XianDao Intelligent and Ningde Times are making significant advancements in solid-state battery production equipment and technology [7] Group 5: Semiconductor Material Innovations - The launch of a silicon carbide semiconductor production project highlights the growing importance of wide bandgap semiconductors, which offer superior performance compared to traditional silicon-based semiconductors [8] - The silicon carbide market is expected to grow rapidly, driven by demand from AI data centers, AR glasses, and other emerging applications [8] - Companies like TianYue Advanced and XinLian Integrated are expanding their production capabilities in silicon carbide substrates, targeting various high-tech applications [9] Group 6: Cobalt Supply and Market Dynamics - The Democratic Republic of the Congo has extended its temporary ban on cobalt exports, which could impact global cobalt supply by over 100,000 metric tons [10] - The global cobalt production is projected to reach 288,000 metric tons in 2024, with the DRC accounting for approximately 220,000 metric tons, representing a 25% year-on-year increase [10] - Companies like Hanrui Cobalt and Luoyang Molybdenum are significantly increasing their cobalt production, with Hanrui ranking among the top three in global market share [11]

Important Market News - The People's Bank of China and the Hong Kong Monetary Authority launched the Cross-Border Payment System, enhancing cooperation between mainland China and Hong Kong for efficient cross-border payment services, set to go live on June 22, 2025 [1][2] Industry Insights - The Cross-Border Payment System will allow real-time cross-border remittances for residents of both regions, utilizing existing payment infrastructures to provide cheaper and more efficient services [2] - The system enables users to select their preferred currency for transactions, either Renminbi or Hong Kong Dollar, through a mobile banking feature [2] - The application of cross-border payments is expanding, becoming a preferred choice for international transactions and playing a significant role in decentralized finance [2] Technology Developments - A successful trial of an invasive brain-computer interface for restoring motor function in a stroke patient was completed, marking a significant advancement in medical rehabilitation technology [3] - The brain-computer interface technology is expected to evolve into various sectors, including education and entertainment, beyond its initial medical applications [3] AI and Innovation - Huawei's Developer Conference 2025 introduced the HarmonyOS and AI technologies, focusing on user experience improvements through AI personal assistants [4] - The AI market is projected to see significant growth, with expectations that AI smartphones and PCs will capture over 50% and 80% market share in China by 2027, respectively [4] Stock Movements - Youyou Foods announced plans for a share reduction by its actual controller, potentially affecting 3% of the total share capital [5] - Tianrong Tianyu and other companies also reported share reduction plans by major shareholders, indicating potential shifts in stock ownership [6][7]

Macro News - The U.S. President Trump announced the completion of strikes on Iran's Fordow, Natanz, and Isfahan nuclear facilities, which has drawn strong condemnation from China, citing violations of international law and escalating tensions in the Middle East [1][4] - The EU Chamber of Commerce in China criticized the European Commission's decision to exclude Chinese companies from public procurement in the EU, labeling it as unilateral protectionism [4] Industry News - The National Medical Products Administration of China approved measures to support the innovation and development of high-end medical devices, including optimizing special approval procedures and enhancing post-market supervision [7] - The "Clear and Bright: Rectifying AI Technology Abuse" initiative has led to the disposal of over 3,500 non-compliant AI products and the cleaning of over 960,000 pieces of illegal information since its launch in April 2025 [6] Company News - Ping An Life increased its stake in China Merchants Bank's H-shares to 15%, triggering a mandatory disclosure under Hong Kong regulations [9] - ST Jinguang announced it received a decision for stock delisting, with the last trading date expected to be July 18 [9] - Renzi Hang announced that its stock will be subject to risk warnings upon resumption of trading on June 24, with a name change to "ST Renzi Hang" [9] - Lanqi Technology plans to issue H-shares and list on the Hong Kong Stock Exchange [9]